Loss of PDCD4 contributes to enhanced chemoresistance in Glioblastoma Multiforme through de-repression of Bcl-xL translation

Glioblastoma multiforme (GBM) is the most common and aggressive form of tumor of the central nervous system. Despite significant efforts to improve treatments, patient survival rarely exceeds 18 months largely due to the highly chemoresistant nature of these tumors. Importantly, misregulation of the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Liwak, Urszula, Jordan, Lindsay E., Von-Holt, Sally Davidson, Singh, Poonam, Hanson, Jennifer E.L., Lorimer, Ian A., Roncaroli, Federico, Holcik, Martin
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2013
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3824522/
https://ncbi.nlm.nih.gov/pubmed/23965755
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars